Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial - Ars Technica
The interim Phase I trial data was only from 35 people, but results look good so far.... Read More
Source: Ars Technica
Published: 2026-05-28T13:39:49Z
Author: Beth Mole